Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
- PMID: 36389680
- PMCID: PMC9646902
- DOI: 10.3389/fimmu.2022.1050309
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
Abstract
Until May 2022, zoonotic infectious disease monkeypox (MPX) caused by the monkeypox virus (MPXV) was one of the forgotten viruses considered to be geographically limited in African countries even though few cases outside of Africa were identified. Central and West African countries are known to be endemic for MPXV. However, since the number of human MPX cases has rapidly increased outside of Africa the global interest in this virus has markedly grown. The majority of infected people with MPXV have never been vaccinated against smallpox virus. Noteworthily, the MPXV spreads fast in men who have sex with men (MSM). Preventive measures against MPXV are essential to be taken, indeed, vaccination is the key. Due to the antigenic similarities, the smallpox vaccine is efficient against MPXV. Nevertheless, there is no specific MPXV vaccine until now. Nucleic acid vaccines deserve special attention since the emergency approval of two messenger RNA (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines in 2020. This milestone in vaccinology has opened a new platform for developing more mRNA- or DNA-based vaccines. Certainly, this type of vaccine has a number of advantages including time- and cost-effectiveness over conventional vaccines. The platform of nucleic acid-based vaccines gives humankind a huge opportunity. Ultimately, there is a strong need for developing a universal vaccine against MPXV. This review will shed the light on the strategies for developing nucleic acid vaccines against MPXV in a timely manner. Consequently, developing nucleic acid-based vaccines may alleviate the global threat against MPXV.
Keywords: DNA vaccine; MPXV; mRNA vaccine; monkeypox virus; pandemic; universal vaccine.
Copyright © 2022 Papukashvili, Rcheulishvili, Liu, Wang, He and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Monkeypox: A New Threat?Int J Mol Sci. 2022 Jul 17;23(14):7866. doi: 10.3390/ijms23147866. Int J Mol Sci. 2022. PMID: 35887214 Free PMC article. Review.
-
Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis.J Infect Public Health. 2023 Apr;16(4):531-541. doi: 10.1016/j.jiph.2023.02.003. Epub 2023 Feb 9. J Infect Public Health. 2023. PMID: 36801633 Free PMC article. Review.
-
Monkeypox virus vaccine evolution and global preparedness for vaccination.Int Immunopharmacol. 2022 Dec;113(Pt A):109346. doi: 10.1016/j.intimp.2022.109346. Epub 2022 Oct 20. Int Immunopharmacol. 2022. PMID: 36274490 Free PMC article.
-
Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment.J Clin Virol. 2024 Apr;171:105662. doi: 10.1016/j.jcv.2024.105662. Epub 2024 Feb 28. J Clin Virol. 2024. PMID: 38432097 Review.
-
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.Nat Commun. 2023 Sep 23;14(1):5948. doi: 10.1038/s41467-023-41587-x. Nat Commun. 2023. PMID: 37741831 Free PMC article.
Cited by
-
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine.Front Microbiol. 2023 Jul 21;14:1203355. doi: 10.3389/fmicb.2023.1203355. eCollection 2023. Front Microbiol. 2023. PMID: 37547674 Free PMC article.
-
Current status of next-generation vaccines against mpox virus: a scoping review.Front Pharmacol. 2025 Apr 28;16:1533533. doi: 10.3389/fphar.2025.1533533. eCollection 2025. Front Pharmacol. 2025. PMID: 40356988 Free PMC article. Review.
-
A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.Vaccines (Basel). 2023 Aug 25;11(9):1420. doi: 10.3390/vaccines11091420. Vaccines (Basel). 2023. PMID: 37766097 Free PMC article.
-
Complete Genome Sequence Analysis of the First Imported Mpox Virus Clade Ib Variant in China.Pathogens. 2025 Jan 20;14(1):102. doi: 10.3390/pathogens14010102. Pathogens. 2025. PMID: 39861063 Free PMC article.
-
Monkeypox virus protein H3L induces injuries in human and mouse.Cell Death Dis. 2024 Aug 21;15(8):607. doi: 10.1038/s41419-024-06990-2. Cell Death Dis. 2024. PMID: 39168969 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical